Valganciclovir must be phosphorylated by HSV-thymidine kinase from the GEN2 vector; active ganciclovir triphosphate is incorporated into DNA and inhibits DNA polymerases, causing chain termination and killing HSV‑TK–transduced tumor cells, not cells merely expressing DNA polymerase epsilon.